2024-517924-20-00Active, not recruitingPhase 1/2
PIGMENT – PDE6A gene therapy for retinitis pigmentosa
Source: EU CTIS (euclinicaltrials.eu) · Last updated 17 Jul 2025
- Status (registry)
- Active, not recruiting
- Phase (registry)
- Phase 1/2
- Study type
- Interventional
- Enrollment
- 9 (estimated)
- First submitted
- 10 Sept 2024
- Start date
- 24 Sept 2019
- Lead sponsor
- Universitaetsklinikum Tuebingen AöR
- Diseases
- Retinitis pigmentosa
- EU CT number
- 2024-517924-20-00
- EudraCT number
- 2016-003705-34
What you commit to
- Study type: Interventional · Phase 1/2
- Planned participants: 9
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universitaetsklinikum Tuebingen AöR | Tuebingen | Germany | Active, not recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.